Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy

Abstract Hepatocellular carcinoma (HCC) remains a global health challenge owing to its widespread incidence and high mortality. HCC has a specific immune tolerance function because of its unique physiological structure, which limits the efficacy of chemotherapy, radiotherapy, and molecular targeting...

Full description

Saved in:
Bibliographic Details
Main Authors: Minni Zhang, Kailin Huang, Qiushi Yin, Xueqin Wu, Mingyue Zhu, Mengsen Li
Format: Article
Language:English
Published: Springer 2025-01-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-01747-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544490962124800
author Minni Zhang
Kailin Huang
Qiushi Yin
Xueqin Wu
Mingyue Zhu
Mengsen Li
author_facet Minni Zhang
Kailin Huang
Qiushi Yin
Xueqin Wu
Mingyue Zhu
Mengsen Li
author_sort Minni Zhang
collection DOAJ
description Abstract Hepatocellular carcinoma (HCC) remains a global health challenge owing to its widespread incidence and high mortality. HCC has a specific immune tolerance function because of its unique physiological structure, which limits the efficacy of chemotherapy, radiotherapy, and molecular targeting. In recent years, new immune approaches, including adoptive cell therapy, tumor vaccines, and oncolytic virus therapy, have shown great potential. As the efficacy of immunotherapy mainly depends on the spatial heterogeneity of the tumor immune microenvironment, it is necessary to elucidate the crosstalk between the composition of the liver cancer immune environment, from which potential therapeutic targets can be selected to provide more appropriate individualized treatment programs. The role of spatial heterogeneity of immune cells in the microenvironment of HCC in the progression and influence of immunotherapy on improving the treatment and prognosis of HCC were comprehensively analyzed, providing new inspiration for the subsequent clinical treatment of liver cancer.
format Article
id doaj-art-177343f783b848f5b6a534787dfc4915
institution Kabale University
issn 2730-6011
language English
publishDate 2025-01-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-177343f783b848f5b6a534787dfc49152025-01-12T12:29:10ZengSpringerDiscover Oncology2730-60112025-01-0116112110.1007/s12672-025-01747-5Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapyMinni Zhang0Kailin Huang1Qiushi Yin2Xueqin Wu3Mingyue Zhu4Mengsen Li5Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical UniversityHainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical UniversityHainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical UniversityHainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical UniversityHainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical UniversityHainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical UniversityAbstract Hepatocellular carcinoma (HCC) remains a global health challenge owing to its widespread incidence and high mortality. HCC has a specific immune tolerance function because of its unique physiological structure, which limits the efficacy of chemotherapy, radiotherapy, and molecular targeting. In recent years, new immune approaches, including adoptive cell therapy, tumor vaccines, and oncolytic virus therapy, have shown great potential. As the efficacy of immunotherapy mainly depends on the spatial heterogeneity of the tumor immune microenvironment, it is necessary to elucidate the crosstalk between the composition of the liver cancer immune environment, from which potential therapeutic targets can be selected to provide more appropriate individualized treatment programs. The role of spatial heterogeneity of immune cells in the microenvironment of HCC in the progression and influence of immunotherapy on improving the treatment and prognosis of HCC were comprehensively analyzed, providing new inspiration for the subsequent clinical treatment of liver cancer.https://doi.org/10.1007/s12672-025-01747-5Hepatocellular carcinomaSpatial heterogeneityTumor microenvironmentImmunotherapy
spellingShingle Minni Zhang
Kailin Huang
Qiushi Yin
Xueqin Wu
Mingyue Zhu
Mengsen Li
Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
Discover Oncology
Hepatocellular carcinoma
Spatial heterogeneity
Tumor microenvironment
Immunotherapy
title Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
title_full Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
title_fullStr Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
title_full_unstemmed Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
title_short Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
title_sort spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
topic Hepatocellular carcinoma
Spatial heterogeneity
Tumor microenvironment
Immunotherapy
url https://doi.org/10.1007/s12672-025-01747-5
work_keys_str_mv AT minnizhang spatialheterogeneityofthehepatocellularcarcinomamicroenvironmentdeterminestheefficacyofimmunotherapy
AT kailinhuang spatialheterogeneityofthehepatocellularcarcinomamicroenvironmentdeterminestheefficacyofimmunotherapy
AT qiushiyin spatialheterogeneityofthehepatocellularcarcinomamicroenvironmentdeterminestheefficacyofimmunotherapy
AT xueqinwu spatialheterogeneityofthehepatocellularcarcinomamicroenvironmentdeterminestheefficacyofimmunotherapy
AT mingyuezhu spatialheterogeneityofthehepatocellularcarcinomamicroenvironmentdeterminestheefficacyofimmunotherapy
AT mengsenli spatialheterogeneityofthehepatocellularcarcinomamicroenvironmentdeterminestheefficacyofimmunotherapy